Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bemiparin prophylaxis for catheter-related deep vein thrombosis in cancer patients
2004-004826-28Phase 3Completed
- Sponsor
- Cima Universidad de Navarra
- Start
- Nov 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in deep vein thrombosis (DVT) and cancer comparing Bemiparin 3500 IU/day with Placebo (2 arms). Primary endpoint: Composite incidence of thrombotic events during treatment period. Started Nov 2005; status: completed.
02
Drugs
bemiparin
03
Conditions
deep vein thrombosis (DVT)cancer
Beyond the preview
Go deeper on 2004-004826-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004826-28.